Back to search

Treatment of the anemia of myelodysplastic syndromes using recombinant human granulocyte colony-stimulating factor in combination with erythropoietin [see comments]

Data up to Jan 2025

Published1993
Citations159
References32

Total Citations Per Year

Abstract

References (32)

Proposals for the classification of the myelodysplastic syndromes

1982 • 3,616 citations

Recombinant Human Granulocyte Colony-Stimulating Factor: Effects on Normal and Leukemic Myeloid Cells

1986 • 1,260 citations

Effects of Recombinant Human Granulocyte–Macrophage Colony-Stimulating Factor in Patients with Myelodysplastic Syndromes

1987 • 653 citations

Effects of Recombinant Human Granulocyte Colony-Stimulating Factor on Neutropenia in Patients with Congenital Agranulocytosis

1989 • 495 citations

Clonal analysis of myelodysplastic syndromes: evidence of multipotent stem cell origin

1989 • 312 citations

Phase I/II study of recombinant human granulocyte-macrophage colony- stimulating factor in aplastic anemia and myelodysplastic syndrome

1988 • 301 citations

PRELEUKEMIC ACUTE HUMAN LEUKEMIA

1953 • 297 citations

Recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes--a phase I/II trial

1989 • 293 citations

Morphological classification, response to therapy, and survival in 263 adult patients with acute nonlymphoblastic leukemia

1980 • 292 citations

Maintenance treatment of patients with myelodysplastic syndromes using recombinant human granulocyte colony-stimulating factor

1990 • 238 citations

Effects of recombinant human interleukin-3 in patients with myelodysplastic syndromes

1990 • 236 citations

Growth factor requirements for survival in G0 and entry into the cell cycle of primitive human hemopoietic progenitors.

1992 • 224 citations

Treatment of Myelodysplastic Syndromes with Recombinant Human Granulocyte Colony-Stimulating Factor

1989 • 208 citations

Subcutaneous granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndrome: toxicity, pharmacokinetics, and hematological effects.

1989 • 179 citations

The smoldering myeloid leukemic states: clinical and biologic features

1983 • 163 citations

Phase I study of recombinant human interleukin-3 in patients with bone marrow failure.

1991 • 148 citations

Pharmacologic doses of recombinant human erythropoietin in the treatment of myelodysplastic syndromes [see comments]

1991 • 144 citations

The treatment of anaemia in the myelodysplastic syndromes with recombinant human erythropoietin

1991 • 131 citations

Pharmacologic doses of recombinant human erythropoietin in the treatment of myelodysplastic syndromes [see comments]

1991 • 117 citations

Effect of chemotherapy for the dysmyelopoietic syndrome.

1981 • 112 citations

A phase II trial of recombinant human granulocyte colony‐stimulating factor in the myelodysplastic syndromes

1991 • 96 citations

Improvement of anemia by recombinant erythropoietin in patients with myelodysplastic syndromes and aplastic anemia

1990 • 94 citations

Circulating erythropoietin in patients with myelodysplastic syndromes

1989 • 94 citations

High-dose recombinant human erythropoietin for treatment of anemia in myelodysplastic syndromes and paroxysmal nocturnal hemoglobinuria: a pilot study.

1990 • 83 citations

Treatment of myelodysplastic syndromes with recombinant human erythropoietin

1991 • 70 citations

Recombinant human erythropoietin in patients with myelodysplastic syndromes.

1991 • 68 citations

Effect of subcutaneously administered human recombinant erythropoietin on erythropoiesis in patients with myelodysplasia

1991 • 66 citations

In vitro culture techniques defining biological abnormalities in the myelodysplastic syndromes and myeloproliferative disorders.

1986 • 65 citations

Effective natural interferon-alpha therapy in recombinant interferon- alpha-resistant patients with hairy cell leukemia

1991 • 63 citations

EVOLUTION OF THE MYELODYSPLASTIC SYNDROMES

1986 • 62 citations

Recombinant human erythropoietin for treatment of myelodysplastic syndromes.

1992 • 39 citations

In vitro marrow culture studies in the myelodysplastic syndromes.

1992 • 18 citations

Cited By (0)

No citing papers found in database

Treatment of the anemia of myelodysplastic syndromes using recombinant human granulocyte… (1993) – Blood | Metascience Observatory Explorer